China Pharma Holdings CPHI
NYSE CPHI
$0.78 -0.06 (-7.30%)
As of: Sep 9, 2026 · 3:59 PM EDT

China Pharma Holdings (CPHI) Other Working Capital Changes (2019 - 2026)

China Pharma Holdings' (CPHI) quarterly Other Working Capital Changes came in at $1.5 million in Q1 2020, up 12025.36% on a YoY basis from N/an in Q2 2019, and up 714748.78% quarter-over-quarter from -$205.0 in Q4 2019.

Analysis

China Pharma Holdings (CPHI) Other Working Capital Changes (2019 - 2026) Analysis & Trends

China Pharma Holdings (CPHI) has reported Other Working Capital Changes for 11 consecutive years, with $1.5 million the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Other Working Capital Changes rose 12025.36% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2020 stood at $1.5 million (up 2619.64% YoY), and the FY2019 full-year result was -$12875.0, up 48.76% from the prior year.
  • Other Working Capital Changes grew to $1.5 million in Q1 2020 per CPHI's latest filing, from -$205.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $452021.0 in Q4 2022 and bottomed at -$392021.0 in Q1 2023.
  • Historically, Other Working Capital Changes has averaged -$3547.0 across 5 years, with a median of -$42449.5 in 2025.
  • The sharpest annual moves came in 2018 and 2020: Other Working Capital Changes slumped 1145.57% in 2018, then soared 12025.36% in 2020.
  • Over 5 years, Other Working Capital Changes stood at -$166976.0 in 2016, then soared by 94.62% to -$8976.0 in 2017, then plunged by 1145.57% to -$111802.0 in 2018, then surged by 99.82% to -$205.0 in 2019, then jumped by 714748.78% to $1.5 million in 2020.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.5 million, -$205.0, and -$44218.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 China Pharma Holdings 31.39 Mn 31.08 Mn 83,566.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89,409.00
Jun 30, 2026 89,409.00
Mar 31, 2026 -51,376.00
Mar 31, 2026 -51,376.00
Jun 30, 2025 -36,880.00
Jun 30, 2025 -36,880.00
Mar 31, 2025 -48,019.00
Mar 31, 2025 -48,019.00
Dec 31, 2024 139,322.00
Dec 31, 2024 139,322.00
Sep 30, 2024 -76,748.00
Sep 30, 2024 -76,748.00
Jun 30, 2024 -10,840.00
Jun 30, 2024 -10,840.00
Mar 31, 2024 21,982.00
Mar 31, 2024 21,982.00
Dec 31, 2023 -82,849.00
Dec 31, 2023 -82,849.00
Sep 30, 2023 118,587.00
Sep 30, 2023 118,587.00